Prophylactic antiangiogenic tumor treatment.
Complementary antitumor treatments are required to increase the cure rate achieved by surgery and/or radiotherapy by avoiding future recurrences and metastases. The growth of most solid tumors, particularly carcinomas, depends upon the simultaneous development of internal tumor vasculature to allow the proliferation of tumor cells. Inhibition of tumor vascularization is an indirect means of limiting tumor expansion. Daily administration of cortisone and maltose tetrapalmitate (MTP) abolished growth of implanted syngeneic C3HBA mammary tumor. Gross and macroscopic examination of these tumors revealed that tumor growth was prevented. Histological examination demonstrated lack of vascularization within the neoplastic tissue. We believe that this combination in an appropriate form could provide a prophylactic treatment regimen after conventional antitumor treatments in humans.
Madarnas
P
P
Département de Pathologie, Faculté de Médecine, Université de Sherbooke, Québec, Canada.
Benrezzak
O
O
Nigam
V N
VN
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use*; D005260:Female; D006017:Glycolipids / Q000627:therapeutic use*; D008325:Mammary Neoplasms, Experimental / Q000098:blood supply* / Q000188:drug therapy / Q000473:pathology; D051379:Mice; D008809:Mice, Inbred C3H; D009389:Neovascularization, Pathologic
D000970:Antineoplastic Agents; D006017:Glycolipids; C017482:maltose tetrapalmitate; D003348:Cortisone